Paperpal Prime Logo

Therapeutic Advances in Infectious Disease : Impact Factor & More

eISSN: 2049-937XpISSN: 2049-9361
JournalOpen Access

Key Metrics

CiteScore
1.5
SJR
Q4Infectious Diseases
SNIP
0.8
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Therapeutic Advances in Infectious Disease

Therapeutic Advances in Infectious Disease Journal Specifications

Overview
Publisher SAGE PUBLICATIONS LTD
Language English
Frequency Continuous publication
Article Processing ChargesUSD 1500
Publication Time9
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2013
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 9
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC BY-NC
OA statementVisit website
View less

Planning to publish in Therapeutic Advances in Infectious Disease ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Therapeutic Advances in Infectious Disease

Treatment gaps and risk factors for multidrug-resistant Enterobacterales in Belize: a 6-year (2018\u20132023) nationwide retrospective analysis
  • 16 Jun 2026
  • Therapeutic Advances in Infectious Disease
Secondary spontaneous pneumothorax due to extensive pulmonary tuberculosis in a patient with acute hepatitis B flare: clinical challenges and therapeutic decision making\u2014a case report
  • 14 Jun 2026
  • Therapeutic Advances in Infectious Disease
Precision geospatial targeting for cost-effective tuberculosis case finding in Eastern Uganda: a quasi-experimental study
  • 11 Jun 2026
  • Therapeutic Advances in Infectious Disease
Bacterial neonatal sepsis, antimicrobial resistance, and risk factors among neonates in Ethiopia: a systematic review and meta-analysis
  • 28 May 2026
  • Therapeutic Advances in Infectious Disease
Community perspectives on hepatitis B transmission and vaccination among adults in Northwest Ethiopia: a qualitative study
  • 26 May 2026
  • Therapeutic Advances in Infectious Disease
Late-onset cytomegalovirus pneumonia after autologous stem cell transplantation for angioimmunoblastic T-cell lymphoma: a case report
  • 22 May 2026
  • Therapeutic Advances in Infectious Disease
Treatment gaps and risk factors for multidrug-resistant Enterobacterales in Belize: a 6-year (2018\u20132023) nationwide retrospective analysis
  • 16 Jun 2026
  • Therapeutic Advances in Infectious Disease
Secondary spontaneous pneumothorax due to extensive pulmonary tuberculosis in a patient with acute hepatitis B flare: clinical challenges and therapeutic decision making\u2014a case report
  • 14 Jun 2026
  • Therapeutic Advances in Infectious Disease
Precision geospatial targeting for cost-effective tuberculosis case finding in Eastern Uganda: a quasi-experimental study
  • 11 Jun 2026
  • Therapeutic Advances in Infectious Disease
Bacterial neonatal sepsis, antimicrobial resistance, and risk factors among neonates in Ethiopia: a systematic review and meta-analysis
  • 28 May 2026
  • Therapeutic Advances in Infectious Disease
Community perspectives on hepatitis B transmission and vaccination among adults in Northwest Ethiopia: a qualitative study
  • 26 May 2026
  • Therapeutic Advances in Infectious Disease
Late-onset cytomegalovirus pneumonia after autologous stem cell transplantation for angioimmunoblastic T-cell lymphoma: a case report
  • 22 May 2026
  • Therapeutic Advances in Infectious Disease

FAQs on Therapeutic Advances in Infectious Disease